Research on BPC-157 Arginate has been ongoing since 1991 and results thereof indicate that the peptide has the ability to repair damaged teeth, bones, muscles, tendons, and even intestines
Blood pressure reductions, improvements in lipid profiles (lower triglycerides, higher HDL), reductions in waist circumference, and decreases in inflammatory markers have been documented for both
The receptors do not care whether you took the dose on time or early
About one in five (19%) adults ages 50-64 say they have ever taken GLP-1 drugs, higher than the shares reported by other age groups
Evidence graded using GRADE-style confidence levels
In the additional analysis comparing the GLP1 receptor agonist group with the SGLT2 inhibitor group, the hazard ratio for thyroid cancer was 1.16